BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu R, Zhang C, Hu Z, Li G, Wang C, Yang C, Huang D, Chen X, Zhang H, Zhuang R. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer. 2011;47:784-791. [PMID: 21112772 DOI: 10.1016/j.ejca.2010.10.025] [Cited by in Crossref: 298] [Cited by in F6Publishing: 288] [Article Influence: 24.8] [Reference Citation Analysis]
Number Citing Articles
1 Huang R, Chen Z, He L, He N, Xi Z, Li Z, Deng Y, Zeng X. Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application. Theranostics 2017;7:3559-72. [PMID: 28912895 DOI: 10.7150/thno.20797] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
2 Creemers EE, Tijsen AJ, Pinto YM, van Rooij E. Circulating MicroRNAs: Novel Biomarkers and Extracellular Communicators in Cardiovascular Disease? Circ Res 2012;110:483-95. [DOI: 10.1161/circresaha.111.247452] [Cited by in Crossref: 652] [Cited by in F6Publishing: 392] [Article Influence: 65.2] [Reference Citation Analysis]
3 Quek C, Bellingham SA, Jung CH, Scicluna BJ, Shambrook MC, Sharples RA, Cheng L, Hill AF. Defining the purity of exosomes required for diagnostic profiling of small RNA suitable for biomarker discovery. RNA Biol 2017;14:245-58. [PMID: 28005467 DOI: 10.1080/15476286.2016.1270005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
4 Wang J, Zhang KY, Liu SM, Sen S. Tumor-associated circulating microRNAs as biomarkers of cancer. Molecules. 2014;19:1912-1938. [PMID: 24518808 DOI: 10.3390/molecules19021912] [Cited by in Crossref: 104] [Cited by in F6Publishing: 104] [Article Influence: 13.0] [Reference Citation Analysis]
5 Zhou X, Wang X, Huang Z, Xu L, Zhu W, Liu P. An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer. J Exp Clin Cancer Res 2014;33:94. [PMID: 25373603 DOI: 10.1186/s13046-014-0094-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
6 Wang BG, Li JS, Liu YF, Xu Q. MicroRNA-200b suppresses the invasion and migration of hepatocellular carcinoma by downregulating RhoA and circRNA_000839. Tumour Biol 2017;39:1010428317719577. [PMID: 28695771 DOI: 10.1177/1010428317719577] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
7 Huang S, Wang J, Li J, Luo Q, Zhao M, Zheng L, Dong X, Chen C, Che Y, Liu P. Serum microRNA expression profile as a diagnostic panel for gastric cancer. Jpn J Clin Oncol. 2016;46:811-818. [PMID: 27380811 DOI: 10.1093/jjco/hyw085] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
8 Wan QS, Zhang KH. Noninvasive detection of gastric cancer. Tumour Biol. 2016;37:11633-11643. [PMID: 27381515 DOI: 10.1007/s13277-016-5129-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
9 Liu L, Cao L, Gong B, Yu J. Novel biomarkers for the identification and targeted therapy of gastric cancer. Expert Rev Gastroenterol Hepatol 2015;9:1217-26. [PMID: 26220043 DOI: 10.1586/17474124.2015.1072466] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
10 Xie S, Chang Y, Jin H, Yang F, Xu Y, Yan X, Lin A, Shu Q, Zhou T. Non-coding RNAs in gastric cancer. Cancer Lett 2020;493:55-70. [PMID: 32712234 DOI: 10.1016/j.canlet.2020.06.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
11 Zabaleta J. MicroRNA: A Bridge from H. pylori Infection to Gastritis and Gastric Cancer Development. Front Genet. 2012;3:294. [PMID: 23248648 DOI: 10.3389/fgene.2012.00294] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
12 Ma Y, Liu Y, Pu YS, Cui ML, Mao ZJ, Li ZZ, He L, Wu M, Wang JH. LncRNA IGFL2-AS1 functions as a ceRNA in regulating ARPP19 through competitive binding to miR-802 in gastric cancer. Mol Carcinog 2020;59:311-22. [PMID: 31943339 DOI: 10.1002/mc.23155] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
13 Leja M, Wex T, Malfertheiner P. Markers for gastric cancer premalignant lesions: where do we go? Dig Dis. 2012;30:268-276. [PMID: 22722551 DOI: 10.1159/000336990] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
14 Yan L, Sun K, Liu Y, Liang J, Cai K, Gui J. MiR-129-5p influences the progression of gastric cancer cells through interacting with SPOCK1. Tumour Biol 2017;39:1010428317706916. [PMID: 28653880 DOI: 10.1177/1010428317706916] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
15 Bhome R, Del Vecchio F, Lee GH, Bullock MD, Primrose JN, Sayan AE, Mirnezami AH. Exosomal microRNAs (exomiRs): Small molecules with a big role in cancer. Cancer Lett. 2018;420:228-235. [PMID: 29425686 DOI: 10.1016/j.canlet.2018.02.002] [Cited by in Crossref: 83] [Cited by in F6Publishing: 85] [Article Influence: 20.8] [Reference Citation Analysis]
16 Wu HH, Lin WC, Tsai KW. Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers. Expert Rev Mol Med. 2014;16:e1. [PMID: 24456939 DOI: 10.1017/erm.2013.16] [Cited by in Crossref: 101] [Cited by in F6Publishing: 103] [Article Influence: 12.6] [Reference Citation Analysis]
17 Annese T, Tamma R, De Giorgis M, Ribatti D. microRNAs Biogenesis, Functions and Role in Tumor Angiogenesis. Front Oncol 2020;10:581007. [PMID: 33330058 DOI: 10.3389/fonc.2020.581007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
18 Tsai KW, Liao YL, Wu CW, Hu LY, Li SC, Chan WC, Ho MR, Lai CH, Kao HW, Fang WL. Aberrant expression of miR-196a in gastric cancers and correlation with recurrence. Genes Chromosomes Cancer. 2012;51:394-401. [PMID: 22420029 DOI: 10.1002/gcc.21924] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 6.1] [Reference Citation Analysis]
19 Xia J, Guo X, Yan J, Deng K. The role of miR-148a in gastric cancer. J Cancer Res Clin Oncol. 2014;140:1451-1456. [PMID: 24659367 DOI: 10.1007/s00432-014-1649-8] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
20 Fang Z, Tang J, Bai Y, Lin H, You H, Jin H, Lin L, You P, Li J, Dai Z, Liang X, Su Y, Hu Q, Wang F, Zhang ZY. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma. J Exp Clin Cancer Res 2015;34:86. [PMID: 26297223 DOI: 10.1186/s13046-015-0198-6] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 11.1] [Reference Citation Analysis]
21 Abdi E, Latifi-navid S, Abdi F, Taherian-esfahani Z. Emerging circulating MiRNAs and LncRNAs in upper gastrointestinal cancers. Expert Review of Molecular Diagnostics 2020;20:1121-38. [DOI: 10.1080/14737159.2020.1842199] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
22 Deng Z, Wu J, Xu S, Chen F, Zhang Z, Jin A, Wang J. Exosomes-microRNAs interacted with gastric cancer and its microenvironment: a mini literature review. Biomark Med 2020;14:141-50. [PMID: 32064893 DOI: 10.2217/bmm-2019-0387] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
23 Tang W, Zhu J, Su S, Wu W, Liu Q, Su F, Yu F. MiR-27 as a prognostic marker for breast cancer progression and patient survival. PLoS One 2012;7:e51702. [PMID: 23240057 DOI: 10.1371/journal.pone.0051702] [Cited by in Crossref: 87] [Cited by in F6Publishing: 80] [Article Influence: 8.7] [Reference Citation Analysis]
24 Zheng GD, Xu ZY, Hu C, Lv H, Xie HX, Huang T, Zhang YQ, Chen GP, Fu YF, Cheng XD. Exosomal miR-590-5p in Serum as a Biomarker for the Diagnosis and Prognosis of Gastric Cancer. Front Mol Biosci 2021;8:636566. [PMID: 33681295 DOI: 10.3389/fmolb.2021.636566] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
25 Han X, Zhang JJ, Han ZQ, Zhang HB, Wang ZA. Let-7b attenuates cisplatin resistance and tumor growth in gastric cancer by targeting AURKB. Cancer Gene Ther 2018;25:300-8. [PMID: 30237418 DOI: 10.1038/s41417-018-0048-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
26 Jiang X, Wang W, Yang Y, Du L, Yang X, Wang L, Zheng G, Duan W, Wang R, Zhang X, Wang L, Chen X, Wang C. Identification of circulating microRNA signatures as potential noninvasive biomarkers for prediction and prognosis of lymph node metastasis in gastric cancer. Oncotarget. 2017;8:65132-65142. [PMID: 29029418 DOI: 10.18632/oncotarget.17789] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
27 Wang Y, Wang H, Zhang C, Zhang C, Yang H, Gao R, Tong Z. Plasma Hsa-miR-92a-3p in correlation with lipocalin-2 is associated with sepsis-induced coagulopathy. BMC Infect Dis 2020;20:155. [PMID: 32075600 DOI: 10.1186/s12879-020-4853-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Hui A, How C, Ito E, Liu FF. Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies. BMC Cancer. 2011;11:500. [PMID: 22128797 DOI: 10.1186/147-2407-11-500] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Shi J, Qu YP, Hou P. Pathogenetic mechanisms in gastric cancer. World J Gastroenterol 2014; 20(38): 13804-13819 [PMID: 25320518 DOI: 10.3748/wjg.v20.i38.13804] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 49] [Article Influence: 6.4] [Reference Citation Analysis]
30 Jiang X, Du L, Duan W, Wang R, Yan K, Wang L, Li J, Zheng G, Zhang X, Yang Y, Wang C. Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer. Oncotarget 2016;7:36733-42. [PMID: 27167342 DOI: 10.18632/oncotarget.9166] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
31 Duan J, Zhang H, Qu Y, Deng T, Huang D, Liu R, Zhang L, Bai M, Zhou L, Ying G, Ba Y. Onco-miR-130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer. Oncotarget 2016;7:44522-33. [PMID: 27304191 DOI: 10.18632/oncotarget.9936] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 10.5] [Reference Citation Analysis]
32 Safa A, Bahroudi Z, Shoorei H, Majidpoor J, Abak A, Taheri M, Ghafouri-Fard S. miR-1: A comprehensive review of its role in normal development and diverse disorders. Biomed Pharmacother 2020;132:110903. [PMID: 33096351 DOI: 10.1016/j.biopha.2020.110903] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
33 Wu C, Wang C, Guan X, Liu Y, Li D, Zhou X, Zhang Y, Chen X, Wang J, Zen K, Zhang CY, Zhang C. Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma. PLoS One. 2014;9:e92292. [PMID: 24651474 DOI: 10.1371/journal.pone.0092292] [Cited by in Crossref: 74] [Cited by in F6Publishing: 72] [Article Influence: 9.3] [Reference Citation Analysis]
34 Bai SY, Ji R, Wei H, Guo QH, Yuan H, Chen ZF, Wang YP, Liu Z, Yang XY, Zhou YN. Serum miR-551b-3p is a potential diagnostic biomarker for gastric cancer. Turk J Gastroenterol 2019;30:415-9. [PMID: 31060996 DOI: 10.5152/tjg.2019.17875] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
35 Toiyama Y, Okugawa Y, Goel A. DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer. Biochem Biophys Res Commun. 2014;455:43-57. [PMID: 25128828 DOI: 10.1016/j.bbrc.2014.08.001] [Cited by in Crossref: 100] [Cited by in F6Publishing: 98] [Article Influence: 12.5] [Reference Citation Analysis]
36 Wei H, Pu K, Liu XG, Li BX, Zhang HS, Wang H, Wang H, Sun WM, Wang YP. The diagnostic value of circulating microRNAs as a biomarker for gastric cancer: A meta‑analysis. Oncol Rep 2019;41:87-102. [PMID: 30320349 DOI: 10.3892/or.2018.6782] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
37 Xiang M, Zeng Y, Yang R, Xu H, Chen Z, Zhong J, Xie H, Xu Y, Zeng X. U6 is not a suitable endogenous control for the quantification of circulating microRNAs. Biochem Biophys Res Commun. 2014;454:210-214. [PMID: 25450382 DOI: 10.1016/j.bbrc.2014.10.064] [Cited by in Crossref: 131] [Cited by in F6Publishing: 137] [Article Influence: 16.4] [Reference Citation Analysis]
38 An Y, Gao S, Zhao WC, Qiu BA, Xia NX, Zhang PJ, Fan ZP. Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma. World J Gastroenterol 2018; 24(24): 2596-2604 [PMID: 29962816 DOI: 10.3748/wjg.v24.i24.2596] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
39 Aldridge S, Hadfield J. Introduction to miRNA Profiling Technologies and Cross-Platform Comparison. In: Fan J, editor. Next-Generation MicroRNA Expression Profiling Technology. Totowa: Humana Press; 2012. pp. 19-31. [DOI: 10.1007/978-1-61779-427-8_2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
40 Xin R, Bai F, Feng Y, Jiu M, Liu X, Bai F, Nie Y, Fan D. MicroRNA-214 promotes peritoneal metastasis through regulating PTEN negatively in gastric cancer. Clin Res Hepatol Gastroenterol 2016;40:748-54. [PMID: 27339596 DOI: 10.1016/j.clinre.2016.05.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
41 Li MH, Fu SB, Xiao HS. Genome-wide analysis of microRNA and mRNA expression signatures in cancer. Acta Pharmacol Sin 2015;36:1200-11. [PMID: 26299954 DOI: 10.1038/aps.2015.67] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 6.1] [Reference Citation Analysis]
42 Keshavarzi M, Sorayayi S, Jafar Rezaei M, Mohammadi M, Ghaderi A, Rostamzadeh A, Masoudifar A, Mirzaei H. MicroRNAs‐Based Imaging Techniques in Cancer Diagnosis and Therapy. J Cell Biochem 2017;118:4121-8. [DOI: 10.1002/jcb.26012] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 11.2] [Reference Citation Analysis]
43 Tsujiura M, Ichikawa D, Konishi H, Komatsu S, Shiozaki A, Otsuji E. Liquid biopsy of gastric cancer patients: Circulating tumor cells and cell-free nucleic acids. World J Gastroenterol 2014; 20(12): 3265-3286 [PMID: 24696609 DOI: 10.3748/wjg.v20.i12.3265] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
44 Shigeyasu K, Toden S, Zumwalt TJ, Okugawa Y, Goel A. Emerging Role of MicroRNAs as Liquid Biopsy Biomarkers in Gastrointestinal Cancers. Clin Cancer Res. 2017;23:2391-2399. [PMID: 28143873 DOI: 10.1158/1078-0432.ccr-16-1676] [Cited by in Crossref: 50] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
45 Song J, Liu Y, Wang T, Li B, Zhang S. MiR-17-5p promotes cellular proliferation and invasiveness by targeting RUNX3 in gastric cancer. Biomed Pharmacother 2020;128:110246. [PMID: 32447210 DOI: 10.1016/j.biopha.2020.110246] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
46 Alipoor SD, Mortaz E, Garssen J, Movassaghi M, Mirsaeidi M, Adcock IM. Exosomes and Exosomal miRNA in Respiratory Diseases. Mediators Inflamm 2016;2016:5628404. [PMID: 27738390 DOI: 10.1155/2016/5628404] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 9.5] [Reference Citation Analysis]
47 Xiao P, Ling H, Lan G, Liu J, Hu H, Yang R. Trefoil factors: Gastrointestinal-specific proteins associated with gastric cancer. Clin Chim Acta. 2015;450:127-134. [PMID: 26265233 DOI: 10.1016/j.cca.2015.08.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
48 Shu L, Wang Z, Wang Q, Wang Y, Zhang X. Signature miRNAs in peripheral blood monocytes of patients with gastric or breast cancers. Open Biol 2018;8:180051. [PMID: 30381359 DOI: 10.1098/rsob.180051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
49 Weng Y, Chen Y, Chen J, Liu Y, Bao T. Identification of serum microRNAs in genome-wide serum microRNA expression profiles as novel noninvasive biomarkers for malignant peripheral nerve sheath tumor diagnosis. Med Oncol 2013;30:531. [PMID: 23483452 DOI: 10.1007/s12032-013-0531-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
50 Zou D, Wu W, Zhang J, Ma Q, Fan S, Cheng J, Li D, Niu J, Qian X, Li W, Cui D. Multiplex detection of miRNAs based on aggregation-induced emission luminogen encoded microspheres. RSC Adv 2019;9:39976-85. [DOI: 10.1039/c9ra07680h] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
51 Bhat SA, Majid S, Rehman MU. Scenario and future prospects of microRNAs in gastric cancer: A review. Iran J Basic Med Sci 2019;22:345-52. [PMID: 31168337 DOI: 10.22038/ijbms.2019.32399.7765] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
52 Theophilou G, Paraskevaidi M, Lima KM, Kyrgiou M, Martin-hirsch PL, Martin FL. Extracting biomarkers of commitment to cancer development: potential role of vibrational spectroscopy in systems biology. Expert Review of Molecular Diagnostics 2015;15:693-713. [DOI: 10.1586/14737159.2015.1028372] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
53 Wei X, Tan C, Tang C, Ren G, Xiang T, Qiu Z, Liu R, Wu Z. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma. Cell Signal. 2013;25:1037-1043. [PMID: 23376496 DOI: 10.1016/j.cellsig.2013.01.019] [Cited by in Crossref: 65] [Cited by in F6Publishing: 73] [Article Influence: 7.2] [Reference Citation Analysis]
54 Uchôa Guimarães CT, Ferreira Martins NN, Cristina da Silva Oliveira K, Almeida CM, Pinheiro TM, Gigek CO, Roberto de Araújo Cavallero S, Assumpção PP, Cardoso Smith MA, Burbano RR, Calcagno DQ. Liquid biopsy provides new insights into gastric cancer. Oncotarget 2018;9:15144-56. [PMID: 29599934 DOI: 10.18632/oncotarget.24540] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
55 Wu C, Li M, Hu C, Duan H. Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma. Mol Biol Rep. 2014;41:1257-1266. [PMID: 24390317 DOI: 10.1007/s11033-013-2970-z] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 6.6] [Reference Citation Analysis]
56 Duan ZY, Cai GY, Bu R, Lu Y, Hou K, Chen XM. Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy. Sci Rep 2016;6:23498. [PMID: 27000966 DOI: 10.1038/srep23498] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
57 Zhang Q, Xu M, Qu Y, Li Z, Zhang Q, Cai X, Lu L. Analysis of the differential expression of circulating microRNAs during the progression of hepatic fibrosis in patients with chronic hepatitis B virus infection. Mol Med Rep. 2015;12:5647-5654. [PMID: 26299203 DOI: 10.3892/mmr.2015.4221] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
58 Liu HS, Xiao HS. MicroRNAs as potential biomarkers for gastric cancer. World J Gastroenterol 2014; 20(34): 12007-12017 [PMID: 25232237 DOI: 10.3748/wjg.v20.i34.12007] [Cited by in CrossRef: 70] [Cited by in F6Publishing: 75] [Article Influence: 8.8] [Reference Citation Analysis]
59 He H, Feng M, Xu H, Li X, He Y, Qin H, Zhang Y, Tang H, Zou K. Total triterpenoids from the fruits of Chaenomeles speciosa exerted gastroprotective activities on indomethacin-induced gastric damage via modulating microRNA-423-5p-mediated TFF/NAG-1 and apoptotic pathways. Food Funct 2020;11:662-79. [PMID: 31895380 DOI: 10.1039/c9fo02322d] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
60 Calanzani N, Druce PE, Snudden C, Milley KM, Boscott R, Behiyat D, Saji S, Martinez-Gutierrez J, Oberoi J, Funston G, Messenger M, Emery J, Walter FM. Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Upper Gastrointestinal Cancers: A Systematic Review. Adv Ther 2021;38:793-834. [PMID: 33306189 DOI: 10.1007/s12325-020-01571-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
61 Wang J, Liu Y, Sun W, Zhang Q, Gu T, Li G. Plasma exosomes as novel biomarker for the early diagnosis of gastric cancer. Cancer Biomark 2018;21:805-12. [PMID: 29400660 DOI: 10.3233/CBM-170738] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
62 Wang M, Zhao C, Shi H, Zhang B, Zhang L, Zhang X, Wang S, Wu X, Yang T, Huang F. Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer. Br J Cancer. 2014;110:1199-1210. [PMID: 24473397 DOI: 10.1038/bjc.2014.14] [Cited by in Crossref: 120] [Cited by in F6Publishing: 129] [Article Influence: 15.0] [Reference Citation Analysis]
63 Wang R, Wen H, Xu Y, Chen Q, Luo Y, Lin Y, Luo Y, Xu A. Circulating microRNAs as a novel class of diagnostic biomarkers in gastrointestinal tumors detection: a meta-analysis based on 42 articles. PLoS One. 2014;9:e113401. [PMID: 25406082 DOI: 10.1371/journal.pone.0113401] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
64 Akbas F, Coskunpinar E, Aynaci E, Oltulu YM, Yildiz P. Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease. Exp Lung Res. 2012;38:286-294. [PMID: 22686440 DOI: 10.3109/01902148.2012.689088] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 6.9] [Reference Citation Analysis]
65 Chen Z, Liu X, Hu Z, Wang Y, Liu M, Liu X, Li H, Ji R, Guo Q, Zhou Y. Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer. Oncol Lett 2015;10:329-36. [PMID: 26171025 DOI: 10.3892/ol.2015.3179] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
66 Zhang H, Duan J, Qu Y, Deng T, Liu R, Zhang L, Bai M, Li J, Ning T, Ge S, Wang X, Wang Z, Fan Q, Li H, Ying G, Huang D, Ba Y. Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer. Protein Cell 2016;7:141-51. [PMID: 26758252 DOI: 10.1007/s13238-015-0234-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 6.2] [Reference Citation Analysis]
67 Vychytilova-Faltejskova P, Slaby O. Circulating Blood-Borne microRNAs as Biomarkers in Solid Tumors. Exp Suppl 2015;106:75-122. [PMID: 26608200 DOI: 10.1007/978-3-0348-0955-9_4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
68 Li D, Liu Y, Li H, Peng J, Tan Y, Zou Q, Song X, Du M, Yang Z, Tan Y, Zhou J, Xu T, Fu Z, Feng J, Cheng P, chen T, Wei D, Su X, Liu H, Qi Z, Tang L, Wang T, Guo X, Hu Y, Zhang T. MicroRNA-1 promotes apoptosis of hepatocarcinoma cells by targeting apoptosis inhibitor-5 (API-5). FEBS Letters 2015;589:68-76. [DOI: 10.1016/j.febslet.2014.11.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
69 Nooh M, Hakemi-Vala M, Nowroozi J, Fatemi SR, Dezfulian M. Prediction of Blood miRNA-mRNA Regulatory Network in Gastric Cancer. Rep Biochem Mol Biol 2021;10:243-56. [PMID: 34604414 DOI: 10.52547/rbmb.10.2.243] [Reference Citation Analysis]
70 Xiong Q, Xu L, Li Q, Li HM, Lou T, Wang AJ, Liu P, Lv NH. Expression profile of circulating microRNAs in patients with irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2013; 21(5): 392-396 [DOI: 10.11569/wcjd.v21.i5.392] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
71 Li BS, Zhao YL, Guo G, Li W, Zhu ED, Luo X, Mao XH, Zou QM, Yu PW, Zuo QF. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS One. 2012;7:e41629. [PMID: 22860003 DOI: 10.1371/journal.pone.0041629] [Cited by in Crossref: 141] [Cited by in F6Publishing: 150] [Article Influence: 14.1] [Reference Citation Analysis]
72 Du L, Jiang X, Duan W, Wang R, Wang L, Zheng G, Yan K, Wang L, Li J, Zhang X, Pan H, Yang Y, Wang C. Cell-free microRNA expression signatures in urine serve as novel noninvasive biomarkers for diagnosis and recurrence prediction of bladder cancer. Oncotarget 2017;8:40832-42. [PMID: 28388561 DOI: 10.18632/oncotarget.16586] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
73 Ma R, Jiang T, Kang X. Circulating microRNAs in cancer: origin, function and application. J Exp Clin Cancer Res. 2012;31:38. [PMID: 22546315 DOI: 10.1186/1756-9966-31-38] [Cited by in Crossref: 126] [Cited by in F6Publishing: 118] [Article Influence: 12.6] [Reference Citation Analysis]
74 Iwasaki H, Shimura T, Yamada T, Okuda Y, Natsume M, Kitagawa M, Horike SI, Kataoka H. A novel urinary microRNA biomarker panel for detecting gastric cancer. J Gastroenterol. 2019;54:1061-1069. [PMID: 31240436 DOI: 10.1007/s00535-019-01601-w] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
75 Han C, Zhou Y, An Q, Li F, Li D, Zhang X, Yu Z, Zheng L, Duan Z, Kan Q. MicroRNA-1 (miR-1) inhibits gastric cancer cell proliferation and migration by targeting MET. Tumour Biol. 2015;Epub ahead of print. [PMID: 25874496 DOI: 10.1007/s13277-015-3358-6] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 6.6] [Reference Citation Analysis]
76 Jia W, Wu Y, Zhang Q, Gao GE, Zhang C, Xiang Y. Expression profile of circulating microRNAs as a promising fingerprint for cervical cancer diagnosis and monitoring. Mol Clin Oncol 2015;3:851-8. [PMID: 26171195 DOI: 10.3892/mco.2015.560] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 6.6] [Reference Citation Analysis]
77 Gu J, Li X, Li H, Jin Z, Jin J. MicroRNA-198 inhibits proliferation and induces apoptosis by directly suppressing FGFR1 in gastric cancer. Biosci Rep 2019;39:BSR20181258. [PMID: 31138759 DOI: 10.1042/BSR20181258] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
78 Li C, Li JF, Cai Q, Qiu QQ, Yan M, Liu BY, Zhu ZG. miRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer. Ann Surg Oncol. 2013;20 Suppl 3:S397-S405. [PMID: 22956063 DOI: 10.1245/s10434-012-2600-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
79 Yu J, Wang R, Chen J, Wu J, Dang Z, Zhang Q, Li B. miR-340 Inhibits Proliferation and Induces Apoptosis in Gastric Cancer Cell Line SGC-7901, Possibly via the AKT Pathway. Med Sci Monit 2017;23:71-7. [PMID: 28057912 DOI: 10.12659/msm.898449] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
80 Keller A, Backes C, Leidinger P, Kefer N, Boisguerin V, Barbacioru C, Vogel B, Matzas M, Huwer H, Katus HA. Next-generation sequencing identifies novel microRNAs in peripheral blood of lung cancer patients. Mol Biosyst. 2011;7:3187-3199. [PMID: 22027949 DOI: 10.1039/c1mb05353a] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 4.1] [Reference Citation Analysis]
81 Wang C, Yang C, Chen X, Yao B, Yang C, Zhu C, Li L, Wang J, Li X, Shao Y, Liu Y, Ji J, Zhang J, Zen K, Zhang C, Zhang C. Altered Profile of Seminal Plasma MicroRNAs in the Molecular Diagnosis of Male Infertility. Clinical Chemistry 2011;57:1722-31. [DOI: 10.1373/clinchem.2011.169714] [Cited by in Crossref: 144] [Cited by in F6Publishing: 139] [Article Influence: 13.1] [Reference Citation Analysis]
82 Li M, Song Q, Li H, Lou Y, Wang L. Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma. PLoS One 2015;10:e0132403. [PMID: 26168287 DOI: 10.1371/journal.pone.0132403] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
83 Song MY, Pan KF, Su HJ, Zhang L, Ma JL, Li JY, Yuasa Y, Kang D, Kim YS, You WC. Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PLoS One. 2012;7:e33608. [PMID: 22432036 DOI: 10.1371/journal.pone.0033608] [Cited by in Crossref: 122] [Cited by in F6Publishing: 129] [Article Influence: 12.2] [Reference Citation Analysis]
84 Ma C, Nguyen HPT, Luwor RB, Stylli SS, Gogos A, Paradiso L, Kaye AH, Morokoff AP. A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker. PLoS One 2018;13:e0189452. [PMID: 29444091 DOI: 10.1371/journal.pone.0189452] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
85 Blanco-Calvo M, Calvo L, Figueroa A, Haz-Conde M, Antón-Aparicio L, Valladares-Ayerbes M. Circulating microRNAs: molecular microsensors in gastrointestinal cancer. Sensors (Basel) 2012;12:9349-62. [PMID: 23012546 DOI: 10.3390/s120709349] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
86 Li YJ, Dong M, Kong FM, Zhou JP, Liang D, Xue HZ. MicroRNA-371-5p targets SOX2 in gastric cancer. Oncotarget 2016;7:31993-2005. [PMID: 27015119 DOI: 10.18632/oncotarget.8289] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
87 Yen TM, Zhang T, Chen PW, Ku TH, Chiu YJ, Lian I, Lo YH. Self-Assembled Pico-Liter Droplet Microarray for Ultrasensitive Nucleic Acid Quantification. ACS Nano 2015;9:10655-63. [PMID: 26435065 DOI: 10.1021/acsnano.5b03848] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
88 Lian F, Cui Y, Zhou C, Gao K, Wu L. Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma. PLoS One 2015;10:e0121499. [PMID: 25775010 DOI: 10.1371/journal.pone.0121499] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 8.4] [Reference Citation Analysis]
89 Kumar P, Dezso Z, MacKenzie C, Oestreicher J, Agoulnik S, Byrne M, Bernier F, Yanagimachi M, Aoshima K, Oda Y. Circulating miRNA biomarkers for Alzheimer's disease. PLoS One. 2013;8:e69807. [PMID: 23922807 DOI: 10.1371/journal.pone.0069807] [Cited by in Crossref: 199] [Cited by in F6Publishing: 187] [Article Influence: 22.1] [Reference Citation Analysis]
90 Park JL, Kim M, Song KS, Kim SY, Kim YS. Cell-Free miR-27a, a Potential Diagnostic and Prognostic Biomarker for Gastric Cancer. Genomics Inform. 2015;13:70-75. [PMID: 26523130 DOI: 10.5808/gi.2015.13.3.70] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
91 Deng S, Zhang X, Qin Y, Chen W, Fan H, Feng X, Wang J, Yan R, Zhao Y, Cheng Y, Wei Y, Fan X, Ashktorab H, Smoot D, Meltzer SJ, Li S, Li K, Peng Y, Jin Z. miRNA-192 and -215 activate Wnt/β-catenin signaling pathway in gastric cancer via APC. J Cell Physiol 2020;235:6218-29. [PMID: 32091625 DOI: 10.1002/jcp.29550] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
92 Pan Z, Tian Y, Niu G, Cao C. The Emerging Role of GC-MSCs in the Gastric Cancer Microenvironment: From Tumor to Tumor Immunity. Stem Cells Int 2019;2019:8071842. [PMID: 31885627 DOI: 10.1155/2019/8071842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
93 Tsai MM, Wang CS, Tsai CY, Huang CG, Lee KF, Huang HW, Lin YH, Chi HC, Kuo LM, Lu PH, Lin KH. Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer. Eur J Cancer. 2016;64:137-148. [PMID: 27420607 DOI: 10.1016/j.ejca.2016.05.007] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
94 Konoshenko MY, Bryzgunova OE, Laktionov PP. miRNAs and radiotherapy response in prostate cancer. Andrology 2021;9:529-45. [PMID: 33053272 DOI: 10.1111/andr.12921] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
95 Hu F, Liu J, Liu H, Li F, Wan M, Zhang M, Jiang Y, Rao M. Role of Exosomal Non-coding RNAs in Gastric Cancer: Biological Functions and Potential Clinical Applications. Front Oncol 2021;11:700168. [PMID: 34195097 DOI: 10.3389/fonc.2021.700168] [Reference Citation Analysis]
96 Gorur A, Balci Fidanci S, Dogruer Unal N, Ayaz L, Akbayir S, Yildirim Yaroglu H, Dirlik M, Serin MS, Tamer L. Determination of plasma microRNA for early detection of gastric cancer. Mol Biol Rep. 2013;40:2091-2096. [PMID: 23212612 DOI: 10.1007/s11033-012-2267-7] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
97 Zhang W, Zhang C, Chen H, Li L, Tu Y, Liu C, Shi S, Zen K, Liu Z. Evaluation of microRNAs miR-196a, miR-30a-5P, and miR-490 as biomarkers of disease activity among patients with FSGS. Clin J Am Soc Nephrol 2014;9:1545-52. [PMID: 25107948 DOI: 10.2215/CJN.11561113] [Cited by in Crossref: 58] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
98 Sekar D, Krishnan R, Thirugnanasambantham K, Rajasekaran B, Islam VI, Sekar P. Significance of microRNA 21 in gastric cancer. Clin Res Hepatol Gastroenterol 2016;40:538-45. [PMID: 27179559 DOI: 10.1016/j.clinre.2016.02.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.8] [Reference Citation Analysis]
99 Qin J, Liang H, Shi D, Dai J, Xu Z, Chen D, Chen X, Jiang Q. A panel of microRNAs as a new biomarkers for the detection of deep vein thrombosis. J Thromb Thrombolysis 2015;39:215-21. [PMID: 25244974 DOI: 10.1007/s11239-014-1131-0] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 8.5] [Reference Citation Analysis]
100 Nakamura K, Sawada K, Yoshimura A, Kinose Y, Nakatsuka E, Kimura T. Clinical relevance of circulating cell-free microRNAs in ovarian cancer. Mol Cancer 2016;15:48. [PMID: 27343009 DOI: 10.1186/s12943-016-0536-0] [Cited by in Crossref: 92] [Cited by in F6Publishing: 91] [Article Influence: 15.3] [Reference Citation Analysis]
101 Izumi D, Zhu Z, Chen Y, Toden S, Huo X, Kanda M, Ishimoto T, Gu D, Tan M, Kodera Y, Baba H, Li W, Chen J, Wang X, Goel A. Assessment of the Diagnostic Efficiency of a Liquid Biopsy Assay for Early Detection of Gastric Cancer. JAMA Netw Open 2021;4:e2121129. [PMID: 34427680 DOI: 10.1001/jamanetworkopen.2021.21129] [Reference Citation Analysis]
102 Song S, Ajani JA. The role of microRNAs in cancers of the upper gastrointestinal tract. Nat Rev Gastroenterol Hepatol 2013;10:109-18. [PMID: 23165235 DOI: 10.1038/nrgastro.2012.210] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 7.0] [Reference Citation Analysis]
103 Stevens MT, Saunders BM. Targets and regulation of microRNA-652-3p in homoeostasis and disease. J Mol Med (Berl) 2021;99:755-69. [PMID: 33712860 DOI: 10.1007/s00109-021-02060-8] [Reference Citation Analysis]
104 Kalniņa Z, Meistere I, Kikuste I, Tolmanis I, Zayakin P, Linē A. Emerging blood-based biomarkers for detection of gastric cancer. World J Gastroenterol 2015; 21(41): 11636-11653 [PMID: 26556992 DOI: 10.3748/wjg.v21.i41.11636] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
105 Mo MH, Chen L, Fu Y, Wang W, Fu SW. Cell-free Circulating miRNA Biomarkers in Cancer. J Cancer. 2012;3:432-448. [PMID: 23074383 DOI: 10.7150/jca.4919] [Cited by in Crossref: 93] [Cited by in F6Publishing: 93] [Article Influence: 9.3] [Reference Citation Analysis]
106 Sisic L, Vallböhmer D, Stoecklein NH, Blank S, Schmidt T, Driemel C, Möhlendick B, Knoefel WT, Odenthal M, Ott K. Serum microRNA profiles as prognostic or predictive markers in the multimodality treatment of patients with gastric cancer. Oncol Lett 2015;10:869-74. [PMID: 26622585 DOI: 10.3892/ol.2015.3341] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
107 Yu X, Luo L, Wu Y, Yu X, Liu Y, Yu X, Zhao X, Zhang X, Cui L, Ye G. Gastric juice miR-129 as a potential biomarker for screening gastric cancer. Med Oncol. 2013;30:365. [PMID: 23307240 DOI: 10.1007/s12032-012-0365-y] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
108 Sciandra M, De Feo A, Parra A, Landuzzi L, Lollini PL, Manara MC, Mattia G, Pontecorvi G, Baricordi C, Guerzoni C, Bazzocchi A, Longhi A, Scotlandi K. Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma. J Cell Commun Signal 2020;14:335-47. [PMID: 32504411 DOI: 10.1007/s12079-020-00567-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
109 Zhang Z, Li Z, Li Y, Zang A. MicroRNA and signaling pathways in gastric cancer. Cancer Gene Ther 2014;21:305-16. [PMID: 25060632 DOI: 10.1038/cgt.2014.37] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
110 Ishimoto T, Baba H, Izumi D, Sugihara H, Kurashige J, Iwatsuki M, Tan P. Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation: MicroRNA dysregulation in gastric cancer. Int J Cancer 2016;138:1337-49. [DOI: 10.1002/ijc.29627] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
111 Xie M, Dart DA, Guo T, Xing XF, Cheng XJ, Du H, Jiang WG, Wen XZ, Ji JF. MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer. Gastric Cancer 2018;21:41-54. [PMID: 28493075 DOI: 10.1007/s10120-017-0721-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
112 Link Y, Romano A, Bejar J, Schiff E, Dotan Y. Widespread osteoblastic metastases and marked elevation of CA19-9 as a presentation of signet ring cell gastric carcinoma. J Gastrointest Oncol 2016;7:E1-5. [PMID: 27034800 DOI: 10.3978/j.issn.2078-6891.2015.086] [Reference Citation Analysis]
113 Faraldi M, Gerosa L, Gomarasca M, Sansoni V, Perego S, Ziemann E, Banfi G, Lombardi G. A Physically Active Status Affects the Circulating Profile of Cancer-Associated miRNAs. Diagnostics (Basel) 2021;11:820. [PMID: 33946605 DOI: 10.3390/diagnostics11050820] [Reference Citation Analysis]
114 Su ZX, Zhao J, Rong ZH, Wu YG, Geng WM, Qin CK. Diagnostic and prognostic value of circulating miR-18a in the plasma of patients with gastric cancer. Tumour Biol. 2014;35:12119-12125. [PMID: 25416437 DOI: 10.1007/s13277-014-2516-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
115 Tian SB, Yu JC, Liu YQ, Kang WM, Ma ZQ, Ye X, Yan C. MiR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer. World J Gastroenterol 2015; 21(31): 9337-9347 [PMID: 26309359 DOI: 10.3748/wjg.v21.i31.9337] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
116 Ortiz-Quintero B. Cell-free microRNAs in blood and other body fluids, as cancer biomarkers. Cell Prolif 2016;49:281-303. [PMID: 27218664 DOI: 10.1111/cpr.12262] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 10.4] [Reference Citation Analysis]
117 Matsuzaki J, Tsugawa H, Suzuki H. Precision Medicine Approaches to Prevent Gastric Cancer. Gut Liver 2021;15:3-12. [PMID: 31893631 DOI: 10.5009/gnl19257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
118 Selth LA, Townley S, Gillis JL, Ochnik AM, Murti K, Macfarlane RJ, Chi KN, Marshall VR, Tilley WD, Butler LM. Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease. Int J Cancer 2012;131:652-61. [PMID: 22052531 DOI: 10.1002/ijc.26405] [Cited by in Crossref: 130] [Cited by in F6Publishing: 116] [Article Influence: 11.8] [Reference Citation Analysis]
119 Yu DC, Li QG, Ding XW, Ding YT. Circulating MicroRNAs: Potential Biomarkers for Cancer. Int J Mol Sci. 2011;12:2055-2063. [PMID: 21673939 DOI: 10.3390/ijms12032055] [Cited by in Crossref: 67] [Cited by in F6Publishing: 70] [Article Influence: 6.1] [Reference Citation Analysis]
120 Luo J, Chen M, Huang H, Yuan T, Zhang M, Zhang K, Deng S. Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma. Onco Targets Ther. 2013;6:577-583. [PMID: 23723713 DOI: 10.2147/ott.s44215] [Cited by in Crossref: 9] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
121 Price C, Chen J. MicroRNAs in Cancer Biology and Therapy: Current Status and Perspectives. Genes Dis. 2014;1:53-63. [PMID: 25473652 DOI: 10.1016/j.gendis.2014.06.004] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 9.3] [Reference Citation Analysis]
122 Jin FE, Xie B, Xian HZ, Wang JH. Knockdown of miR-125b-5p inhibits the proliferation and invasion of gastric carcinoma cells by targeting RYBP. Kaohsiung J Med Sci 2021. [PMID: 34337862 DOI: 10.1002/kjm2.12425] [Reference Citation Analysis]
123 Zhang J, Zhao H, Gao Y, Zhang W. Secretory miRNAs as novel cancer biomarkers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2012;1826:32-43. [DOI: 10.1016/j.bbcan.2012.03.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
124 Gao M, Yin H, Fei ZW. Clinical application of microRNA in gastric cancer in Eastern Asian area. World J Gastroenterol 2013; 19(13): 2019-2027 [PMID: 23599620 DOI: 10.3748/wjg.v19.i13.2019] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
125 Sonohara F, Inokawa Y, Hayashi M, Kodera Y, Nomoto S. Epigenetic modulation associated with carcinogenesis and prognosis of human gastric cancer. Oncol Lett 2017;13:3363-8. [PMID: 28529571 DOI: 10.3892/ol.2017.5912] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
126 Li Y, Xu Q, Liu J, He C, Yuan Q, Xing C, Yuan Y. Pri-let-7a-1 rs10739971 polymorphism is associated with gastric cancer prognosis and might affect mature let-7a expression. Onco Targets Ther 2016;9:3951-62. [PMID: 27445488 DOI: 10.2147/OTT.S100481] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
127 Wang G, Liu G, Ye Y, Fu Y, Zhang X. Upregulation of miR-34a by diallyl disulfide suppresses invasion and induces apoptosis in SGC-7901 cells through inhibition of the PI3K/Akt signaling pathway. Oncol Lett 2016;11:2661-7. [PMID: 27073535 DOI: 10.3892/ol.2016.4266] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
128 Parvaee P, Sarmadian H, Khansarinejad B, Amini M, Mondanizadeh M. Plasma Level of MicroRNAs, MiR-107, MiR-194 and MiR-210 as Potential Biomarkers for Diagnosis Intestinal-Type Gastric Cancer in Human. Asian Pac J Cancer Prev 2019;20:1421-6. [PMID: 31127902 DOI: 10.31557/APJCP.2019.20.5.1421] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
129 Shin VY, Chu KM. MiRNA as potential biomarkers and therapeutic targets for gastric cancer. World J Gastroenterol 2014; 20(30): 10432-10439 [PMID: 25132759 DOI: 10.3748/wjg.v20.i30.10432] [Cited by in CrossRef: 152] [Cited by in F6Publishing: 154] [Article Influence: 19.0] [Reference Citation Analysis]
130 Girardi C, De Pittà C, Casara S, Sales G, Lanfranchi G, Celotti L, Mognato M. Analysis of miRNA and mRNA expression profiles highlights alterations in ionizing radiation response of human lymphocytes under modeled microgravity. PLoS One 2012;7:e31293. [PMID: 22347458 DOI: 10.1371/journal.pone.0031293] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 7.1] [Reference Citation Analysis]
131 Jamali L, Tofigh R, Tutunchi S, Panahi G, Borhani F, Akhavan S, Nourmohammadi P, Ghaderian SM, Rasouli M, Mirzaei H. Circulating microRNAs as diagnostic and therapeutic biomarkers in gastric and esophageal cancers. J Cell Physiol 2018;233:8538-50. [DOI: 10.1002/jcp.26850] [Cited by in Crossref: 83] [Cited by in F6Publishing: 90] [Article Influence: 20.8] [Reference Citation Analysis]
132 Hu Z, Dong J, Wang LE, Ma H, Liu J, Zhao Y, Tang J, Chen X, Dai J, Wei Q, Zhang C, Shen H. Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls. Carcinogenesis 2012;33:828-34. [PMID: 22298638 DOI: 10.1093/carcin/bgs030] [Cited by in Crossref: 137] [Cited by in F6Publishing: 132] [Article Influence: 13.7] [Reference Citation Analysis]
133 Ramraj SK, Aravindan S, Somasundaram DB, Herman TS, Natarajan M, Aravindan N. Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic disease. Oncotarget 2016;7:18605-19. [PMID: 26921195 DOI: 10.18632/oncotarget.7615] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
134 Zhou X, Zhu W, Li H, Wen W, Cheng W, Wang F, Wu Y, Qi L, Fan Y, Chen Y, Ding Y, Xu J, Qian J, Huang Z, Wang T, Zhu D, Shu Y, Liu P. Diagnostic value of a plasma microRNA signature in gastric cancer: a microRNA expression analysis. Sci Rep. 2015;5:11251. [PMID: 26059512 DOI: 10.1038/srep11251] [Cited by in Crossref: 90] [Cited by in F6Publishing: 90] [Article Influence: 12.9] [Reference Citation Analysis]
135 Tiwari AK, Laird-Fick HS, Wali RK, Roy HK. Surveillance for gastrointestinal malignancies. World J Gastroenterol 2012; 18(33): 4507-4516 [PMID: 22969223 DOI: 10.3748/wjg.v18.i33.4507] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
136 Liang H, Jiang Z, Xie G, Lu Y. Serum microRNA-145 as a novel biomarker in human ovarian cancer. Tumor Biol 2015;36:5305-13. [DOI: 10.1007/s13277-015-3191-y] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 6.1] [Reference Citation Analysis]
137 Nam RK, Benatar T, Amemiya Y, Wallis CJD, Romero JM, Tsagaris M, Sherman C, Sugar L, Seth A. MicroRNA-652 induces NED in LNCaP and EMT in PC3 prostate cancer cells. Oncotarget. 2018;9:19159-19176. [PMID: 29721191 DOI: 10.18632/oncotarget.24937] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
138 罗宇霖, 任美萍, 罗茂. 消化系肿瘤循环微小RNA研究进展. 世界华人消化杂志 2017; 25(16): 1446-1453 [DOI: 10.11569/wcjd.v25.i16.1446] [Cited by in CrossRef: 2] [Article Influence: 0.4] [Reference Citation Analysis]
139 Liu WJ, Xu Q, Sun LP, Dong QG, He CY, Yuan Y. Expression of serum let-7c, let-7i, and let-7f microRNA with its target gene, pepsinogen C, in gastric cancer and precancerous disease. Tumour Biol. 2015;36:3337-3343. [PMID: 25549793 DOI: 10.1007/s13277-014-2967-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
140 Gigek CO, Chen ES, Calcagno DQ, Wisnieski F, Burbano RR, Smith MA. Epigenetic mechanisms in gastric cancer. Epigenomics. 2012;4:279-294. [PMID: 22690664 DOI: 10.2217/epi.12.22] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 7.3] [Reference Citation Analysis]
141 Colín-gonzález AL, Santamaría A. Garlic, Gastrointestinal Protection and Oxidative Stress. Gastrointestinal Tissue. Elsevier; 2017. pp. 275-88. [DOI: 10.1016/b978-0-12-805377-5.00020-5] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
142 Zhang A, Wang C, Lu H, Chen X, Ba Y, Zhang C, Zhang CY. Altered Serum MicroRNA Profile May Serve as an Auxiliary Tool for Discriminating Aggressive Thyroid Carcinoma from Nonaggressive Thyroid Cancer and Benign Thyroid Nodules. Dis Markers 2019;2019:3717683. [PMID: 31636734 DOI: 10.1155/2019/3717683] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
143 Link A, Kupcinskas J, Wex T, Malfertheiner P. Macro-role of microRNA in gastric cancer. Dig Dis. 2012;30:255-267. [PMID: 22722550 DOI: 10.1159/000336919] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 6.8] [Reference Citation Analysis]
144 Nair N, Kumar S, Gongora E, Gupta S. Circulating miRNA as novel markers for diastolic dysfunction. Mol Cell Biochem. 2013;376:33-40. [PMID: 23247724 DOI: 10.1007/s11010-012-1546-x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 5.3] [Reference Citation Analysis]
145 Xu Q, Dong QG, Sun LP, He CY, Yuan Y. Expression of serum miR-20a-5p, let-7a, and miR-320a and their correlations with pepsinogen in atrophic gastritis and gastric cancer: a case-control study. BMC Clin Pathol. 2013;13:11. [PMID: 23521833 DOI: 10.1186/1472-6890-13-11] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
146 Guo R, Fan G, Zhang J, Wu C, Du Y, Ye H, Li Z, Wang L, Zhang Z, Zhang L, Zhao Y, Lu Z. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer’s Disease. JAD 2017;60:1365-77. [DOI: 10.3233/jad-170343] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 8.6] [Reference Citation Analysis]
147 Ribaldone DG, Simondi D, Petrini E, Astegiano M, Durazzo M. Non-invasive biomarkers for gastric cancer diagnosis: ready for prime time? Minerva Biotecnol 2019;31. [DOI: 10.23736/s1120-4826.18.02463-1] [Cited by in Crossref: 6] [Article Influence: 2.0] [Reference Citation Analysis]
148 Silva SS, Lopes C, Teixeira AL, Carneiro de Sousa MJ, Medeiros R. Forensic miRNA: potential biomarker for body fluids? Forensic Sci Int Genet 2015;14:1-10. [PMID: 25280377 DOI: 10.1016/j.fsigen.2014.09.002] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 6.9] [Reference Citation Analysis]
149 Dong QG, Yang YC. Clinical significance of abnormal expression of miR-92a in serum of gastric cancer patients. Shijie Huaren Xiaohua Zazhi 2014; 22(29): 4487-4491 [DOI: 10.11569/wcjd.v22.i29.4487] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
150 Zhi F, Cao X, Xie X, Wang B, Dong W, Gu W, Ling Y, Wang R, Yang Y, Liu Y. Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia. PLoS One 2013;8:e56718. [PMID: 23437222 DOI: 10.1371/journal.pone.0056718] [Cited by in Crossref: 76] [Cited by in F6Publishing: 73] [Article Influence: 8.4] [Reference Citation Analysis]
151 Yuan C, Zhang Y, Tu W, Guo Y. Integrated miRNA profiling and bioinformatics analyses reveal upregulated miRNAs in gastric cancer. Oncol Lett 2019;18:1979-88. [PMID: 31423268 DOI: 10.3892/ol.2019.10495] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
152 Siracusa J, Koulmann N, Banzet S. Circulating myomiRs: a new class of biomarkers to monitor skeletal muscle in physiology and medicine. J Cachexia Sarcopenia Muscle 2018;9:20-7. [PMID: 29193905 DOI: 10.1002/jcsm.12227] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 10.2] [Reference Citation Analysis]
153 Link A, Kupcinskas J. MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives. World J Gastroenterol 2018; 24(30): 3313-3329 [PMID: 30122873 DOI: 10.3748/wjg.v24.i30.3313] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 54] [Article Influence: 12.8] [Reference Citation Analysis]
154 Cui S, Sun B, Yin X, Guo X, Chao D, Zhang C, Zhang CY, Chen X, Ma J. Time-course responses of circulating microRNAs to three resistance training protocols in healthy young men. Sci Rep 2017;7:2203. [PMID: 28526870 DOI: 10.1038/s41598-017-02294-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
155 Javidi MA, Ahmadi AH, Bakhshinejad B, Nouraee N, Babashah S, Sadeghizadeh M. Cell-free microRNAs as cancer biomarkers: the odyssey of miRNAs through body fluids. Med Oncol. 2014;31:295. [PMID: 25362261 DOI: 10.1007/s12032-014-0295-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
156 Selth LA, Townley SL, Gillis JL, Tilley WD, Butler LM. Identification of prostate cancer-associated microRNAs in circulation using a mouse model of disease. Methods Mol Biol 2013;1024:235-46. [PMID: 23719956 DOI: 10.1007/978-1-62703-453-1_19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
157 Walton SJ, Lewis A, Jeffery R, Thompson H, Feakins R, Giannoulatou E, Yau C, Lindsay JO, Clark SK, Silver A. Familial adenomatous patients with desmoid tumours show increased expression of miR-34a in serum and high levels in tumours. Oncoscience 2016;3:173-85. [PMID: 27489864 DOI: 10.18632/oncoscience.312] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
158 Weiland M, Gao XH, Zhou L, Mi QS. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases. RNA Biol. 2012;9:850-859. [PMID: 22699556 DOI: 10.4161/rna.20378] [Cited by in Crossref: 185] [Cited by in F6Publishing: 184] [Article Influence: 18.5] [Reference Citation Analysis]
159 Jorge NA, Ferreira CG, Passetti F. Bioinformatics of Cancer ncRNA in High Throughput Sequencing: Present State and Challenges. Front Genet 2012;3:287. [PMID: 23251139 DOI: 10.3389/fgene.2012.00287] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
160 Menéndez P, Villarejo P, Padilla D, Menéndez JM, Montes JA. Diagnostic and prognostic significance of serum microRNAs in colorectal cancer. J Surg Oncol. 2013;107:217-220. [PMID: 22903548 DOI: 10.1002/jso.23245] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
161 Xu Q, Dong Q, He C, Liu W, Sun L, Liu J, Xing C, Li X, Wang B, Yuan Y. A new polymorphism biomarker rs629367 associated with increased risk and poor survival of gastric cancer in chinese by up-regulated miRNA-let-7a expression. PLoS One. 2014;9:e95249. [PMID: 24760009 DOI: 10.1371/journal.pone.0095249] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
162 Link A, Goel A. MicroRNA in gastrointestinal cancer: a step closer to reality. Adv Clin Chem. 2013;62:221-268. [PMID: 24772669 DOI: 10.1016/b978-0-12-800096-0.00006-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
163 Wang J, Song YX, Wang ZN. Non-coding RNAs in gastric cancer. Gene. 2015;560:1-8. [PMID: 25659765 DOI: 10.1016/j.gene.2015.02.004] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 6.6] [Reference Citation Analysis]
164 Ge Y, Zhao K, Qi Y, Min X, Shi Z, Qi X, Shan Y, Cui L, Zhou M, Wang Y, Wang H, Cui L. Serum microRNA expression profile as a biomarker for the diagnosis of pertussis. Mol Biol Rep 2013;40:1325-32. [PMID: 23073777 DOI: 10.1007/s11033-012-2176-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
165 Stojanovic J, Tognetto A, Tiziano DF, Leoncini E, Posteraro B, Pastorino R, Boccia S. MicroRNAs expression profiles as diagnostic biomarkers of gastric cancer: a systematic literature review. Biomarkers 2019;24:110-9. [DOI: 10.1080/1354750x.2018.1539765] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
166 Li SQ, Chen FJ, Cao XF. Distinctive microRNAs in esophageal tumor: early diagnosis, prognosis judgment, and tumor treatment. Dis Esophagus 2013;26:288-98. [PMID: 22458808 DOI: 10.1111/j.1442-2050.2012.01346.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
167 Lan H, Lu H, Wang X, Jin H. MicroRNAs as potential biomarkers in cancer: opportunities and challenges. Biomed Res Int 2015;2015:125094. [PMID: 25874201 DOI: 10.1155/2015/125094] [Cited by in Crossref: 127] [Cited by in F6Publishing: 149] [Article Influence: 18.1] [Reference Citation Analysis]
168 Kawakami K, Enokida H, Chiyomaru T, Tatarano S, Yoshino H, Kagara I, Gotanda T, Tachiwada T, Nishiyama K, Nohata N. The functional significance of miR-1 and miR-133a in renal cell carcinoma. Eur J Cancer. 2012;48:827-836. [PMID: 21745735 DOI: 10.1016/j.ejca.2011.06.030] [Cited by in Crossref: 92] [Cited by in F6Publishing: 94] [Article Influence: 9.2] [Reference Citation Analysis]
169 Dong H, Li J, Huang L, Chen X, Li D, Wang T, Hu C, Xu J, Zhang C, Zen K, Xiao S, Yan Q, Wang C, Zhang CY. Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer's Disease. Dis Markers 2015;2015:625659. [PMID: 26078483 DOI: 10.1155/2015/625659] [Cited by in Crossref: 73] [Cited by in F6Publishing: 81] [Article Influence: 10.4] [Reference Citation Analysis]
170 Ali S, Saleh H, Sethi S, Sarkar FH, Philip PA. MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer. Br J Cancer. 2012;107:1354-1360. [PMID: 22929886 DOI: 10.1038/bjc.2012.383] [Cited by in Crossref: 85] [Cited by in F6Publishing: 84] [Article Influence: 8.5] [Reference Citation Analysis]
171 Xiong Q, Xu L. Significance of serum microRNAs in patients with gastrointestinal diseases. Shijie Huaren Xiaohua Zazhi 2012; 20(22): 2043-2049 [DOI: 10.11569/wcjd.v20.i22.2043] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
172 Weiss M, Brandenburg LO, Burchardt M, Stope MB. MicroRNA-1 properties in cancer regulatory networks and tumor biology. Crit Rev Oncol Hematol 2016;104:71-7. [PMID: 27286699 DOI: 10.1016/j.critrevonc.2016.05.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
173 Lopez A, Harada K, Mizrak Kaya D, Dong X, Song S, Ajani JA. Liquid biopsies in gastrointestinal malignancies: when is the big day? Expert Review of Anticancer Therapy 2018;18:19-38. [DOI: 10.1080/14737140.2018.1403320] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
174 Li D, Wang Y, Lau C, Lu J. xMAP Array Microspheres Based Stem–Loop Structured Probes as Conformational Switches for Multiplexing Detection of miRNAs. Anal Chem 2014;86:10148-56. [DOI: 10.1021/ac501989b] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
175 Verma M, Rogers S, Divi RL, Schully SD, Nelson S, Joseph Su L, Ross SA, Pilch S, Winn DM, Khoury MJ. Epigenetic research in cancer epidemiology: trends, opportunities, and challenges. Cancer Epidemiol Biomarkers Prev 2014;23:223-33. [PMID: 24326628 DOI: 10.1158/1055-9965.EPI-13-0573] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
176 Rani S, Gately K, Crown J, O'Byrne K, O'Driscoll L. Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinoma. Cancer Biol Ther 2013;14:1104-12. [PMID: 24025412 DOI: 10.4161/cbt.26370] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 5.4] [Reference Citation Analysis]
177 Fernandez-Valverde SL, Taft RJ, Mattick JS. MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications. Diabetes. 2011;60:1825-1831. [PMID: 21709277 DOI: 10.2337/db11-0171] [Cited by in Crossref: 154] [Cited by in F6Publishing: 140] [Article Influence: 14.0] [Reference Citation Analysis]
178 Banerjee S, Chakravarti D, Ganguli S, Roychoudhury S. Cancer Noncoding RNA Discovery Through High-Throughput Sequencing. Cancer and Noncoding RNAs. Elsevier; 2018. pp. 463-77. [DOI: 10.1016/b978-0-12-811022-5.00025-5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
179 Resende C, Thiel A, Machado JC, Ristimäki A. Gastric Cancer: Basic Aspects: Gastric Cancer: Basics. Helicobacter 2011;16:38-44. [DOI: 10.1111/j.1523-5378.2011.00879.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
180 Khoury S, Tran N. Circulating microRNAs: potential biomarkers for common malignancies. Biomark Med. 2015;9:131-151. [PMID: 25689901 DOI: 10.2217/bmm.14.102] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 6.4] [Reference Citation Analysis]
181 Xu Q, Chen TJ, He CY, Sun LP, Liu JW, Yuan Y. MiR-27a rs895819 is involved in increased atrophic gastritis risk, improved gastric cancer prognosis and negative interaction with Helicobacter pylori. Sci Rep 2017;7:41307. [PMID: 28150722 DOI: 10.1038/srep41307] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
182 Xie SS, Jin J, Xu X, Zhuo W, Zhou TH. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications. World J Gastroenterol 2016; 22(3): 1213-1223 [PMID: 26811659 DOI: 10.3748/wjg.v22.i3.1213] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
183 Zheng G, Wang H, Zhang X, Yang Y, Wang L, Du L, Li W, Li J, Qu A, Liu Y. Identification and validation of reference genes for qPCR detection of serum microRNAs in colorectal adenocarcinoma patients. PLoS One. 2013;8:e83025. [PMID: 24349425 DOI: 10.1371/journal.pone.0083025] [Cited by in Crossref: 70] [Cited by in F6Publishing: 72] [Article Influence: 7.8] [Reference Citation Analysis]
184 Bovell LC, Putcha BD, Samuel T, Manne U. Clinical implications of microRNAs in cancer. Biotech Histochem 2013;88:388-96. [PMID: 23647010 DOI: 10.3109/10520295.2013.788735] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
185 Xiao H, Zhang Y, Kim Y, Kim S, Kim JJ, Kim KM, Yoshizawa J, Fan LY, Cao CX, Wong DT. Differential Proteomic Analysis of Human Saliva using Tandem Mass Tags Quantification for Gastric Cancer Detection. Sci Rep 2016;6:22165. [PMID: 26911362 DOI: 10.1038/srep22165] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 9.2] [Reference Citation Analysis]
186 Wu J, Zhang H, Wang W, Zhu M, Qi LW, Wang T, Cheng W, Zhu J, Shan X, Huang Z, Zhang L, Chen Y, Sun B, Zhao X, Qian J, Zhu W, Zhou X, Xing C. Plasma microRNA signature of patients with IgA nephropathy. Gene 2018;649:80-6. [PMID: 29459010 DOI: 10.1016/j.gene.2018.01.050] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
187 Gu Y, Si J, Xiao X, Tian Y, Yang S. miR-92a Inhibits Proliferation and Induces Apoptosis by Regulating Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2) Expression in Acute Myeloid Leukemia. Oncol Res 2017;25:1069-79. [PMID: 28059050 DOI: 10.3727/096504016X14829256525028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
188 Nohata N, Hanazawa T, Enokida H, Seki N. microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers. Oncotarget 2012;3:9-21. [PMID: 22308266 DOI: 10.18632/oncotarget.424] [Cited by in Crossref: 165] [Cited by in F6Publishing: 159] [Article Influence: 16.5] [Reference Citation Analysis]
189 Ichikawa D, Komatsu S, Konishi H, Otsuji E. Circulating microRNA in digestive tract cancers. Gastroenterology. 2012;142:1074-1078.e1. [PMID: 22433392 DOI: 10.1053/j.gastro.2012.03.008] [Cited by in Crossref: 37] [Cited by in F6Publishing: 45] [Article Influence: 3.7] [Reference Citation Analysis]
190 Lee IS, Ahn J, Kim K, Okugawa Y, Toiyama Y, Hur H, Goel A. A blood-based transcriptomic signature for noninvasive diagnosis of gastric cancer. Br J Cancer 2021. [PMID: 34163003 DOI: 10.1038/s41416-021-01461-3] [Reference Citation Analysis]
191 Jia W, Wu Y, Zhang Q, Gao G, Zhang C, Xiang Y. Identification of four serum microRNAs from a genome-wide serum microRNA expression profile as potential non-invasive biomarkers for endometrioid endometrial cancer. Oncol Lett 2013;6:261-7. [PMID: 23946815 DOI: 10.3892/ol.2013.1338] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
192 Wang W, Zhang Y, Zhu B, Duan T, Xu Q, Wang R, Lu L, Jiao Z. Plasma microRNA expression profiles in Chinese patients with rheumatoid arthritis. Oncotarget 2015;6:42557-68. [PMID: 26637811 DOI: 10.18632/oncotarget.6449] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
193 Minemura H, Takagi K, Miki Y, Shibahara Y, Nakagawa S, Ebata A, Watanabe M, Ishida T, Sasano H, Suzuki T. Abnormal expression of miR-1 in breast carcinoma as a potent prognostic factor. Cancer Sci 2015;106:1642-50. [PMID: 26331797 DOI: 10.1111/cas.12808] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
194 Zhu C, Ren C, Han J, Ding Y, Du J, Dai N, Dai J, Ma H, Hu Z, Shen H, Xu Y, Jin G. A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer. Br J Cancer. 2014;110:2291-2299. [PMID: 24595006 DOI: 10.1038/bjc.2014.119] [Cited by in Crossref: 139] [Cited by in F6Publishing: 142] [Article Influence: 17.4] [Reference Citation Analysis]
195 Huang YK, Yu JC. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review. World J Gastroenterol 2015; 21(34): 9863-9886 [PMID: 26379393 DOI: 10.3748/wjg.v21.i34.9863] [Cited by in CrossRef: 84] [Cited by in F6Publishing: 76] [Article Influence: 12.0] [Reference Citation Analysis]
196 Valladares-Ayerbes M, Reboredo M, Medina-Villaamil V, Iglesias-Díaz P, Lorenzo-Patiño MJ, Haz M, Santamarina I, Blanco M, Fernández-Tajes J, Quindós M, Carral A, Figueroa A, Antón-Aparicio LM, Calvo L. Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer. J Transl Med 2012;10:186. [PMID: 22954417 DOI: 10.1186/1479-5876-10-186] [Cited by in Crossref: 95] [Cited by in F6Publishing: 94] [Article Influence: 9.5] [Reference Citation Analysis]
197 Ortega FJ, Mercader JM, Catalán V, Moreno-Navarrete JM, Pueyo N, Sabater M, Gómez-Ambrosi J, Anglada R, Fernández-Formoso JA, Ricart W, Frühbeck G, Fernández-Real JM. Targeting the circulating microRNA signature of obesity. Clin Chem 2013;59:781-92. [PMID: 23396142 DOI: 10.1373/clinchem.2012.195776] [Cited by in Crossref: 244] [Cited by in F6Publishing: 231] [Article Influence: 27.1] [Reference Citation Analysis]
198 Shiotani A, Murao T, Kimura Y, Matsumoto H, Kamada T, Kusunoki H, Inoue K, Uedo N, Iishi H, Haruma K. Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer. Br J Cancer. 2013;109:2323-2330. [PMID: 24104965 DOI: 10.1038/bjc.2013.596] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 6.1] [Reference Citation Analysis]
199 Seronde MF, Vausort M, Gayat E, Goretti E, Ng LL, Squire IB, Vodovar N, Sadoune M, Samuel JL, Thum T, Solal AC, Laribi S, Plaisance P, Wagner DR, Mebazaa A, Devaux Y; GREAT network. Circulating microRNAs and Outcome in Patients with Acute Heart Failure. PLoS One 2015;10:e0142237. [PMID: 26580972 DOI: 10.1371/journal.pone.0142237] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 6.7] [Reference Citation Analysis]
200 Goldman JM, Kim S, Narburgh S, Armitage BA, Schneider JW. Rapid, multiplexed detection of the let-7 miRNA family using γPNA amphiphiles in micelle-tagging electrophoresis. Biopolymers 2021;:e23479. [PMID: 34643943 DOI: 10.1002/bip.23479] [Reference Citation Analysis]
201 da Silva Oliveira KC, Thomaz Araújo TM, Albuquerque CI, Barata GA, Gigek CO, Leal MF, Wisnieski F, Rodrigues Mello Junior FA, Khayat AS, de Assumpção PP, Rodriguez Burbano RM, Smith MC, Calcagno DQ. Role of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancer. World J Gastroenterol 2016; 22(35): 7951-7962 [PMID: 27672290 DOI: 10.3748/wjg.v22.i35.7951] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
202 Kelly BD, Miller N, Sweeney KJ, Durkan GC, Rogers E, Walsh K, Kerin MJ. A Circulating MicroRNA Signature as a Biomarker for Prostate Cancer in a High Risk Group. J Clin Med. 2015;4:1369-1379. [PMID: 26239681 DOI: 10.3390/jcm4071369] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 8.4] [Reference Citation Analysis]
203 Zhao Y, Song Y, Yao L, Song G, Teng C. Circulating microRNAs: Promising Biomarkers Involved in Several Cancers and Other Diseases. DNA and Cell Biology 2017;36:77-94. [DOI: 10.1089/dna.2016.3426] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
204 Zhao R, Zhao L, Xu X, Xu H. Analysis of microRNA expression profiles reveals a 5‑microRNA prognostic signature for predicting overall survival time in patients with gastric adenocarcinoma. Oncol Rep 2019;41:2775-89. [PMID: 30864737 DOI: 10.3892/or.2019.7048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
205 Zhang J, Song Y, Zhang C, Zhi X, Fu H, Ma Y, Chen Y, Pan F, Wang K, Ni J. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer. Theranostics. 2015;5:733-745. [PMID: 25897338 DOI: 10.7150/thno.10305] [Cited by in Crossref: 90] [Cited by in F6Publishing: 87] [Article Influence: 12.9] [Reference Citation Analysis]
206 Friedman EB, Shang S, de Miera EV, Fog JU, Teilum MW, Ma MW, Berman RS, Shapiro RL, Pavlick AC, Hernando E, Baker A, Shao Y, Osman I. Serum microRNAs as biomarkers for recurrence in melanoma. J Transl Med 2012;10:155. [PMID: 22857597 DOI: 10.1186/1479-5876-10-155] [Cited by in Crossref: 96] [Cited by in F6Publishing: 81] [Article Influence: 9.6] [Reference Citation Analysis]
207 Felgendreff P, Raschzok N, Kunze K, Leder A, Lippert S, Klunk S, Tautenhahn H, Hau H, Schmuck RB, Reutzel-selke A, Sauer IM, Bartels M, Morgül MH. Tissue-based miRNA mapping in alcoholic liver cirrhosis: different profiles in cirrhosis with or without hepatocellular carcinoma. Biomarkers 2020;25:62-8. [DOI: 10.1080/1354750x.2019.1691267] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
208 Chung KY, Quek JM, Neo SH, Too HP. Polymer-Based Precipitation of Extracellular Vesicular miRNAs from Serum Improve Gastric Cancer miRNA Biomarker Performance. The Journal of Molecular Diagnostics 2020;22:610-8. [DOI: 10.1016/j.jmoldx.2020.01.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
209 Yang H, Fu H, Wang B, Zhang X, Mao J, Li X, Wang M, Sun Z, Qian H, Xu W. Exosomal miR-423-5p targets SUFU to promote cancer growth and metastasis and serves as a novel marker for gastric cancer. Mol Carcinog. 2018;57:1223-1236. [PMID: 29749061 DOI: 10.1002/mc.22838] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 15.8] [Reference Citation Analysis]
210 Song JH, Meltzer SJ. MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers. Gastroenterology. 2012;143:35-47.e2. [PMID: 22580099 DOI: 10.1053/j.gastro.2012.05.003] [Cited by in Crossref: 118] [Cited by in F6Publishing: 131] [Article Influence: 11.8] [Reference Citation Analysis]
211 Zhi F, Shao N, Wang R, Deng D, Xue L, Wang Q, Zhang Y, Shi Y, Xia X, Wang S, Lan Q, Yang Y. Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma. Neuro Oncol 2015;17:383-91. [PMID: 25140035 DOI: 10.1093/neuonc/nou169] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 6.4] [Reference Citation Analysis]
212 Wu X, Shen J, Xiao Z, Li J, Zhao Y, Zhao Q, Cho CH, Li M. An overview of the multifaceted roles of miRNAs in gastric cancer: Spotlight on novel biomarkers and therapeutic targets. Biochem Pharmacol 2019;163:425-39. [PMID: 30857828 DOI: 10.1016/j.bcp.2019.03.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
213 Han J, Sun W, Liu R, Zhou Z, Zhang H, Chen X, Ba Y. Plasma Exosomal miRNA Expression Profile as Oxaliplatin-Based Chemoresistant Biomarkers in Colorectal Adenocarcinoma. Front Oncol 2020;10:1495. [PMID: 33072545 DOI: 10.3389/fonc.2020.01495] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
214 Yan H, Li M, Cao L, Chen H, Lai H, Guan Q, Chen H, Zhou W, Zheng B, Guo Z, Zheng C. A robust qualitative transcriptional signature for the correct pathological diagnosis of gastric cancer. J Transl Med 2019;17:63. [PMID: 30819200 DOI: 10.1186/s12967-019-1816-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
215 Ma H, Tian Y, Yu X. Targeting Smoothened Sensitizes Gastric Cancer to Chemotherapy in Experimental Models. Med Sci Monit 2017;23:1493-500. [PMID: 28350784 DOI: 10.12659/msm.903012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
216 Huang D, Wang H, Liu R, Li H, Ge S, Bai M, Deng T, Yao G, Ba Y. miRNA27a is a biomarker for predicting chemosensitivity and prognosis in metastatic or recurrent gastric cancer. J Cell Biochem. 2014;115:549-556. [PMID: 24122958 DOI: 10.1002/jcb.24689] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 5.9] [Reference Citation Analysis]
217 Matsuzaki J, Ochiya T. Circulating microRNAs and extracellular vesicles as potential cancer biomarkers: a systematic review. Int J Clin Oncol. 2017;22:413-420. [PMID: 28243946 DOI: 10.1007/s10147-017-1104-3] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 10.4] [Reference Citation Analysis]
218 Chen R, Zheng Y, Zhuo L, Wang S. The association between miR-423 rs6505162 polymorphism and cancer susceptibility: a systematic review and meta-analysis. Oncotarget 2017;8:40204-13. [PMID: 28418884 DOI: 10.18632/oncotarget.16319] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
219 Lin X, Lo HC, Wong DT, Xiao X. Noncoding RNAs in human saliva as potential disease biomarkers. Front Genet 2015;6:175. [PMID: 25999984 DOI: 10.3389/fgene.2015.00175] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
220 Amacher DE. A 2015 survey of established or potential epigenetic biomarkers for the accurate detection of human cancers. Biomarkers 2016;21:387-403. [PMID: 26983778 DOI: 10.3109/1354750X.2016.1153724] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
221 Yang R, Fu Y, Zeng Y, Xiang M, Yin Y, Li L, Xu H, Zhong J, Zeng X. Serum miR-20a is a promising biomarker for gastric cancer. Biomed Rep. 2017;6:429-434. [PMID: 28413641 DOI: 10.3892/br.2017.862] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
222 Hauptman N, Glavac D. MicroRNAs and long non-coding RNAs: prospects in diagnostics and therapy of cancer. Radiol Oncol 2013;47:311-8. [PMID: 24294175 DOI: 10.2478/raon-2013-0062] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 5.2] [Reference Citation Analysis]
223 Tao J, Yang X, Li P, Wei J, Deng X, Cheng Y, Qin C, Ju X, Meng X, Li J, Gu M, Lu Q, Yin C. Identification of circulating microRNA signatures for upper tract urothelial carcinoma detection. Mol Med Rep 2015;12:6752-60. [PMID: 26323574 DOI: 10.3892/mmr.2015.4257] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
224 Ke R, Lv L, Zhang S, Zhang F, Jiang Y. Functional mechanism and clinical implications of MicroRNA-423 in human cancers. Cancer Med 2020;9:9036-51. [PMID: 33174687 DOI: 10.1002/cam4.3557] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
225 Zhang H, Bai M, Deng T, Liu R, Wang X, Qu Y, Duan J, Zhang L, Ning T, Ge S, Li H, Zhou L, Liu Y, Huang D, Ying G, Ba Y. Cell-derived microvesicles mediate the delivery of miR-29a/c to suppress angiogenesis in gastric carcinoma. Cancer Lett 2016;375:331-9. [PMID: 27000664 DOI: 10.1016/j.canlet.2016.03.026] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 10.3] [Reference Citation Analysis]
226 Zhang J, Cao Z, Yang G, You L, Zhang T, Zhao Y. MicroRNA-27a (miR-27a) in Solid Tumors: A Review Based on Mechanisms and Clinical Observations. Front Oncol 2019;9:893. [PMID: 31572683 DOI: 10.3389/fonc.2019.00893] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
227 Hatse S, Brouwers B, Dalmasso B, Laenen A, Kenis C, Schöffski P, Wildiers H. Circulating MicroRNAs as easy-to-measure aging biomarkers in older breast cancer patients: correlation with chronological age but not with fitness/frailty status. PLoS One 2014;9:e110644. [PMID: 25333486 DOI: 10.1371/journal.pone.0110644] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
228 Cai H, Yuan Y, Hao YF, Guo TK, Wei X, Zhang YM. Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer. Med Oncol. 2013;30:452. [PMID: 23307259 DOI: 10.1007/s12032-012-0452-0] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 6.6] [Reference Citation Analysis]
229 Xu J, Han K, Liu D, Lin L, Miao P. Isothermal amplification detection of miRNA based on the catalysis of nucleases and voltammetric characteristics of silver nanoparticles. Mol Biosyst 2016;12:3550-5. [PMID: 27785510 DOI: 10.1039/c6mb00659k] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
230 Pilli T, Cantara S, Marzocchi C, Cardinale S, Santini C, Cevenini G, Pacini F. Diagnostic Value of Circulating microRNA-95 and -190 in the Differential Diagnosis of Thyroid Nodules: A Validation Study in 1000 Consecutive Patients. Thyroid 2017;27:1053-7. [PMID: 28605303 DOI: 10.1089/thy.2017.0035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
231 Li J, Liu Y, Wang C, Deng T, Liang H, Wang Y, Huang D, Fan Q, Wang X, Ning T, Liu R, Zhang CY, Zen K, Chen X, Ba Y. Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma. Sci Rep 2015;5:12921. [PMID: 26250939 DOI: 10.1038/srep12921] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 7.1] [Reference Citation Analysis]
232 Liu R, Zhang H, Wang X, Zhou L, Li H, Deng T, Qu Y, Duan J, Bai M, Ge S, Ning T, Zhang L, Huang D, Ba Y. The miR-24-Bim pathway promotes tumor growth and angiogenesis in pancreatic carcinoma. Oncotarget 2015;6:43831-42. [PMID: 26517093 DOI: 10.18632/oncotarget.6257] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
233 Yan Y, Wang C, Zhou W, Shi Y, Guo P, Liu Y, Wang J, Zhang CY, Zhang C. Elevation of Circulating miR-210-3p in High-Altitude Hypoxic Environment. Front Physiol 2016;7:84. [PMID: 27014085 DOI: 10.3389/fphys.2016.00084] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
234 Brenner B, Hoshen MB, Purim O, David MB, Ashkenazi K, Marshak G, Kundel Y, Brenner R, Morgenstern S, Halpern M, Rosenfeld N, Chajut A, Niv Y, Kushnir M. MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol 2011; 17(35): 3976-3985 [PMID: 22046085 DOI: 10.3748/wjg.v17.i35.3976] [Cited by in CrossRef: 67] [Cited by in F6Publishing: 62] [Article Influence: 6.1] [Reference Citation Analysis]
235 Yuan XP, Liu LS, Chen CB, Zhou J, Zheng YT, Wang XP, Han M, Wang CX. MicroRNA-423-5p facilitates hypoxia/reoxygenation-induced apoptosis in renal proximal tubular epithelial cells by targeting GSTM1 via endoplasmic reticulum stress. Oncotarget. 2017;8:82064-82077. [PMID: 29137244 DOI: 10.18632/oncotarget.18289] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
236 Zou J, Xu Y. MicroRNA-140 Inhibits Cell Proliferation in Gastric Cancer Cell Line HGC-27 by Suppressing SOX4. Med Sci Monit. 2016;22:2243-2252. [PMID: 27353653 DOI: 10.12659/msm.896633] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
237 Hudler P. Challenges of deciphering gastric cancer heterogeneity. World J Gastroenterol 2015; 21(37): 10510-10527 [PMID: 26457012 DOI: 10.3748/wjg.v21.i37.10510] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
238 Zeng Y, Pan Y, Liu H, Kang K, Wu Y, Hui G, Peng W, Ramchandran R, Raj JU, Gou D. MiR-20a regulates the PRKG1 gene by targeting its coding region in pulmonary arterial smooth muscle cells. FEBS Lett 2014;588:4677-85. [PMID: 25447536 DOI: 10.1016/j.febslet.2014.10.040] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
239 Hong Y, Wang C, Fu Z, Liang H, Zhang S, Lu M, Sun W, Ye C, Zhang CY, Zen K, Shi L, Zhang C, Chen X. Systematic characterization of seminal plasma piRNAs as molecular biomarkers for male infertility. Sci Rep 2016;6:24229. [PMID: 27068805 DOI: 10.1038/srep24229] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 6.7] [Reference Citation Analysis]
240 Yu J, Xu Q, Zhang X, Zhu M. Circulating microRNA signatures serve as potential diagnostic biomarkers for Helicobacter pylori infection. J Cell Biochem 2019;120:1735-41. [DOI: 10.1002/jcb.27462] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
241 Huang SL, Ye H, Tang YW, Wu LN, Guo WY, Shen XL, Dong XW, Zhang X. Clinical significance of expression of miR-638 in gastric carcinoma. Shijie Huaren Xiaohua Zazhi 2016; 24(6): 928-932 [DOI: 10.11569/wcjd.v24.i6.928] [Reference Citation Analysis]
242 Hou LK, Ma YS, Han Y, Lu GX, Luo P, Chang ZY, Xie RT, Yang HQ, Chai L, Cai MX, Wu TM, Yu F, Qin SS, Lv ZW, Wu CY, Fu D. Association of microRNA-33a Molecular Signature with Non-Small Cell Lung Cancer Diagnosis and Prognosis after Chemotherapy. PLoS One 2017;12:e0170431. [PMID: 28141816 DOI: 10.1371/journal.pone.0170431] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
243 Hu C, Shen SQ, Cui ZH, Chen ZB, Li W. Effect of microRNA-1 on hepatocellular carcinoma tumor endothelial cells. World J Gastroenterol 2015; 21(19): 5884-5892 [PMID: 26019452 DOI: 10.3748/wjg.v21.i19.5884] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
244 Scott KA, Hoban AE, Clarke G, Moloney GM, Dinan TG, Cryan JF. Thinking small: towards microRNA-based therapeutics for anxiety disorders. Expert Opinion on Investigational Drugs 2015;24:529-42. [DOI: 10.1517/13543784.2014.997873] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
245 Cheng Y, Yang M, Peng J. Correlation the between the regulation of miRNA-1 in c-Met-induced EMT and cervical cancer progression. Oncol Lett 2019;17:3341-9. [PMID: 30867768 DOI: 10.3892/ol.2019.9971] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
246 Song J, Bai Z, Han W, Zhang J, Meng H, Bi J, Ma X, Han S, Zhang Z. Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients. Dig Dis Sci. 2012;57:897-904. [PMID: 22198701 DOI: 10.1007/s10620-011-1981-7] [Cited by in Crossref: 190] [Cited by in F6Publishing: 186] [Article Influence: 17.3] [Reference Citation Analysis]
247 Zhang L, Liao Y, Tang L. MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer. J Exp Clin Cancer Res 2019;38:53. [PMID: 30717802 DOI: 10.1186/s13046-019-1059-5] [Cited by in Crossref: 94] [Cited by in F6Publishing: 105] [Article Influence: 31.3] [Reference Citation Analysis]
248 Mandal S, Zhang X, Pandey S, Mao H. Single-Molecule Topochemical Analyses for Large-Scale Multiplexing Tasks. Anal Chem 2019;91:13485-93. [PMID: 31553880 DOI: 10.1021/acs.analchem.9b02483] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
249 Ouyang L, Liu P, Yang S, Ye S, Xu W, Liu X. A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma. Med Oncol 2013;30. [DOI: 10.1007/s12032-012-0340-7] [Cited by in Crossref: 83] [Cited by in F6Publishing: 85] [Article Influence: 8.3] [Reference Citation Analysis]
250 Al-Rawaf HA. Circulating microRNAs and adipokines as markers of metabolic syndrome in adolescents with obesity. Clin Nutr 2019;38:2231-8. [PMID: 30309709 DOI: 10.1016/j.clnu.2018.09.024] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 9.0] [Reference Citation Analysis]
251 Rotkrua P, Shimada S, Mogushi K, Akiyama Y, Tanaka H, Yuasa Y. Circulating microRNAs as biomarkers for early detection of diffuse-type gastric cancer using a mouse model. Br J Cancer. 2013;108:932-940. [PMID: 23385731 DOI: 10.1038/bjc.2013.30] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 4.2] [Reference Citation Analysis]
252 Wu L, Chen J, Ding C, Wei S, Zhu Y, Yang W, Zhang X, Wei X, Han D. MicroRNA-137 Contributes to Dampened Tumorigenesis in Human Gastric Cancer by Targeting AKT2. PLoS One 2015;10:e0130124. [PMID: 26102366 DOI: 10.1371/journal.pone.0130124] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
253 Zhu X, Lv M, Wang H, Guan W. Identification of circulating microRNAs as novel potential biomarkers for gastric cancer detection: a systematic review and meta-analysis. Dig Dis Sci. 2014;59:911-919. [PMID: 24337687 DOI: 10.1007/s10620-013-2970-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
254 Kim CH, Kim HK, Rettig RL, Kim J, Lee ET, Aprelikova O, Choi IJ, Munroe DJ, Green JE. miRNA signature associated with outcome of gastric cancer patients following chemotherapy. BMC Med Genomics. 2011;4:79. [PMID: 22112324 DOI: 10.1186/1755-8794-4-79] [Cited by in Crossref: 85] [Cited by in F6Publishing: 92] [Article Influence: 7.7] [Reference Citation Analysis]
255 Yin X, Zhao Y, Zheng YL, Wang JZ, Li W, Lu QJ, Huang QN, Zhang CY, Chen X, Ma JZ. Time-Course Responses of Muscle-Specific MicroRNAs Following Acute Uphill or Downhill Exercise in Sprague-Dawley Rats. Front Physiol 2019;10:1275. [PMID: 31632302 DOI: 10.3389/fphys.2019.01275] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
256 Jiang X, Du L, Wang L, Li J, Liu Y, Zheng G, Qu A, Zhang X, Pan H, Yang Y, Wang C. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer: Serum miRNA Signature for BC Detection. Int J Cancer 2015;136:854-62. [DOI: 10.1002/ijc.29041] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 9.3] [Reference Citation Analysis]
257 Qiu X, Zhang J, Shi W, Liu S, Kang M, Chu H, Wu D, Tong N, Gong W, Tao G. Circulating MicroRNA-26a in Plasma and Its Potential Diagnostic Value in Gastric Cancer. PLoS One. 2016;11:e0151345. [PMID: 27010210 DOI: 10.1371/journal.pone.0151345] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
258 De Guire V, Robitaille R, Tétreault N, Guérin R, Ménard C, Bambace N, Sapieha P. Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: promises and challenges. Clin Biochem. 2013;46:846-860. [PMID: 23562576 DOI: 10.1016/j.clinbiochem.2013.03.015] [Cited by in Crossref: 145] [Cited by in F6Publishing: 141] [Article Influence: 16.1] [Reference Citation Analysis]
259 Kottorou A, Dimitrakopoulos FI, Tsezou A. Non-coding RNAs in cancer-associated cachexia: clinical implications and future perspectives. Transl Oncol 2021;14:101101. [PMID: 33915516 DOI: 10.1016/j.tranon.2021.101101] [Reference Citation Analysis]
260 Dong QG, Yuan Y. Research progress of microRNAs and Helicobacter pylori-associated gastric diseases. Shijie Huaren Xiaohua Zazhi 2012; 20(6): 479-485 [DOI: 10.11569/wcjd.v20.i6.479] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
261 Imaoka H, Toiyama Y, Okigami M, Yasuda H, Saigusa S, Ohi M, Tanaka K, Inoue Y, Mohri Y, Kusunoki M. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer. Gastric Cancer. 2016;19:744-753. [PMID: 26233325 DOI: 10.1007/s10120-015-0521-0] [Cited by in Crossref: 50] [Cited by in F6Publishing: 56] [Article Influence: 7.1] [Reference Citation Analysis]
262 Supplitt S, Karpinski P, Sasiadek M, Laczmanska I. Current Achievements and Applications of Transcriptomics in Personalized Cancer Medicine. Int J Mol Sci 2021;22:1422. [PMID: 33572595 DOI: 10.3390/ijms22031422] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
263 Madhavan D, Cuk K, Burwinkel B, Yang R. Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures. Front Genet 2013;4:116. [PMID: 23802013 DOI: 10.3389/fgene.2013.00116] [Cited by in Crossref: 56] [Cited by in F6Publishing: 72] [Article Influence: 6.2] [Reference Citation Analysis]
264 Zheng G, Du L, Yang X, Zhang X, Wang L, Yang Y, Li J, Wang C. Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma. Br J Cancer. 2014;111:1985-1992. [PMID: 25233400 DOI: 10.1038/bjc.2014.489] [Cited by in Crossref: 73] [Cited by in F6Publishing: 81] [Article Influence: 9.1] [Reference Citation Analysis]
265 Li C, Fang Z, Jiang T, Zhang Q, Liu C, Zhang C, Xiang Y. Serum microRNAs profile from genome-wide serves as a fingerprint for diagnosis of acute myocardial infarction and angina pectoris. BMC Med Genomics. 2013;6:16. [PMID: 23641832 DOI: 10.1186/1755-8794-6-16] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 6.7] [Reference Citation Analysis]
266 Wang Y, Zhang Y, Pan C, Ma F, Zhang S. Prediction of poor prognosis in breast cancer patients based on microRNA-21 expression: a meta-analysis. PLoS One 2015;10:e0118647. [PMID: 25706383 DOI: 10.1371/journal.pone.0118647] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
267 Zhou L, Zhao YP, Liu WJ, Dong J, Chen WY, Zhang TP, Chen G, Shu H. Circulating microRNAs in cancer: diagnostic and prognostic significance. Expert Rev Anticancer Ther 2012;12:283-8. [PMID: 22316375 DOI: 10.1586/era.11.197] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
268 Liu L, Wang S, Cao X, Liu J. Diagnostic value of circulating microRNAs for gastric cancer in Asian populations: a meta-analysis. Tumor Biol 2014;35:11995-2004. [DOI: 10.1007/s13277-014-2498-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
269 Zhang Y, Zhang P, Rong Z, Huang C. One stomach, two subtypes of carcinoma—the differences between distal and proximal gastric cancer. Gastroenterology Report 2021;9:489-504. [DOI: 10.1093/gastro/goab050] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
270 Hui A, How C, Ito E, Liu FF. Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies. BMC Cancer 2011;11:500. [PMID: 22128797 DOI: 10.1186/1471-2407-11-500] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
271 Wang H, Zhang P, Chen W, Feng D, Jia Y, Xie L. Serum microRNA signatures identified by Solexa sequencing predict sepsis patients' mortality: a prospective observational study. PLoS One 2012;7:e38885. [PMID: 22719975 DOI: 10.1371/journal.pone.0038885] [Cited by in Crossref: 94] [Cited by in F6Publishing: 95] [Article Influence: 9.4] [Reference Citation Analysis]
272 Wang T, Zang WQ, Li M, Wang N, Zheng YL, Zhao GQ. Effect of miR-451 on the biological behavior of the esophageal carcinoma cell line EC9706. Dig Dis Sci. 2013;58:706-714. [PMID: 23053883 DOI: 10.1007/s10620-012-2395-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
273 Liu J, Wang X, Yang X, Liu Y, Shi Y, Ren J, Guleng B. miRNA423-5p regulates cell proliferation and invasion by targeting trefoil factor 1 in gastric cancer cells. Cancer Lett. 2014;347:98-104. [PMID: 24486742 DOI: 10.1016/j.canlet.2014.01.024] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 7.1] [Reference Citation Analysis]
274 Yin Y, Li J, Chen S, Zhou T, Si J. MicroRNAs as Diagnostic Biomarkers in Gastric Cancer. Int J Mol Sci. 2012;13:12544-12555. [PMID: 23202912 DOI: 10.3390/ijms131012544] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
275 Wang J, Chen J, Sen S. MicroRNA as Biomarkers and Diagnostics. J Cell Physiol. 2016;231:25-30. [PMID: 26031493 DOI: 10.1002/jcp.25056] [Cited by in Crossref: 296] [Cited by in F6Publishing: 291] [Article Influence: 49.3] [Reference Citation Analysis]
276 Wang J, Huang SK, Zhao M, Yang M, Zhong JL, Gu YY, Peng H, Che YQ, Huang CZ. Identification of a circulating microRNA signature for colorectal cancer detection. PLoS One. 2014;9:e87451. [PMID: 24709885 DOI: 10.1371/journal.pone.0087451] [Cited by in Crossref: 99] [Cited by in F6Publishing: 103] [Article Influence: 12.4] [Reference Citation Analysis]
277 Cui SF, Li W, Niu J, Zhang CY, Chen X, Ma JZ. Acute responses of circulating microRNAs to low-volume sprint interval cycling. Front Physiol 2015;6:311. [PMID: 26578983 DOI: 10.3389/fphys.2015.00311] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
278 Luo Y, Tan W, Jia W, Liu Z, Ye P, Fu Z, Lu F, Xiang W, Tang L, Yao L, Huang Q, Xiao J. The long non-coding RNA LINC01606 contributes to the metastasis and invasion of human gastric cancer and is associated with Wnt/β-catenin signaling. The International Journal of Biochemistry & Cell Biology 2018;103:125-34. [DOI: 10.1016/j.biocel.2018.08.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
279 Liu H, Zhu L, Liu B, Yang L, Meng X, Zhang W, Ma Y, Xiao H. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett. 2012;316:196-203. [PMID: 22169097 DOI: 10.1016/j.canlet.2011.10.034] [Cited by in Crossref: 174] [Cited by in F6Publishing: 174] [Article Influence: 15.8] [Reference Citation Analysis]
280 Chakraborty C, Das S. Profiling cell-free and circulating miRNA: a clinical diagnostic tool for different cancers. Tumour Biol. 2016;37:5705-5714. [PMID: 26831657 DOI: 10.1007/s13277-016-4907-3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 7.2] [Reference Citation Analysis]
281 Schwarzenbach H, Nishida N, Calin GA, Pantel K. Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol. 2014;11:145-156. [PMID: 24492836 DOI: 10.1038/nrclinonc.2014.5] [Cited by in Crossref: 621] [Cited by in F6Publishing: 612] [Article Influence: 77.6] [Reference Citation Analysis]
282 Wang Y, Gu J, Roth JA, Hildebrandt MA, Lippman SM, Ye Y, Minna JD, Wu X. Pathway-based serum microRNA profiling and survival in patients with advanced stage non-small cell lung cancer. Cancer Res 2013;73:4801-9. [PMID: 23774211 DOI: 10.1158/0008-5472.CAN-12-3273] [Cited by in Crossref: 69] [Cited by in F6Publishing: 43] [Article Influence: 7.7] [Reference Citation Analysis]
283 Słotwiński R, Lech G, Słotwińska SM. MicroRNAs in pancreatic cancer diagnosis and therapy. Cent Eur J Immunol 2018;43:314-24. [PMID: 30588176 DOI: 10.5114/ceji.2018.80051] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
284 Werner S, Chen H, Butt J, Michel A, Knebel P, Holleczek B, Zörnig I, Eichmüller SB, Jäger D, Pawlita M, Waterboer T, Brenner H. Evaluation of the diagnostic value of 64 simultaneously measured autoantibodies for early detection of gastric cancer. Sci Rep 2016;6:25467. [PMID: 27140836 DOI: 10.1038/srep25467] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
285 Kipkeeva F, Muzaffarova T, Korotaeva A, Nikulin M, Grishina K, Mansorunov D, Apanovich P, Karpukhin A. MicroRNA in Gastric Cancer Development: Mechanisms and Biomarkers. Diagnostics (Basel) 2020;10:E891. [PMID: 33142817 DOI: 10.3390/diagnostics10110891] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
286 Yang N, Ekanem NR, Sakyi CA, Ray SD. Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics. Adv Drug Deliv Rev. 2015;81:62-74. [PMID: 25450260 DOI: 10.1016/j.addr.2014.10.029] [Cited by in Crossref: 108] [Cited by in F6Publishing: 115] [Article Influence: 13.5] [Reference Citation Analysis]
287 Li S, Zhang H, Wang X, Qu Y, Duan J, Liu R, Deng T, Ning T, Zhang L, Bai M, Zhou L, Wang X, Ge S, Ying G, Ba Y. Direct targeting of HGF by miR-16 regulates proliferation and migration in gastric cancer. Tumor Biol 2016;37:15175-83. [DOI: 10.1007/s13277-016-5390-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
288 Yang C, Wang C, Chen X, Chen S, Zhang Y, Zhi F, Wang J, Li L, Zhou X, Li N, Pan H, Zhang J, Zen K, Zhang CY, Zhang C. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas. Int J Cancer. 2013;132:116-127. [PMID: 22674182 DOI: 10.1002/ijc.27657] [Cited by in Crossref: 130] [Cited by in F6Publishing: 123] [Article Influence: 13.0] [Reference Citation Analysis]
289 Tijsen AJ, Pinto YM, Creemers EE. Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases. Am J Physiol Heart Circ Physiol 2012;303:H1085-95. [PMID: 22942181 DOI: 10.1152/ajpheart.00191.2012] [Cited by in Crossref: 140] [Cited by in F6Publishing: 130] [Article Influence: 14.0] [Reference Citation Analysis]
290 Jian B, Li Z, Xiao D, He G, Bai L, Yang Q. Downregulation of microRNA-193-3p inhibits tumor proliferation migration and chemoresistance in human gastric cancer by regulating PTEN gene. Tumour Biol. 2016;37:8941-8949. [PMID: 26753960 DOI: 10.1007/s13277-015-4727-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
291 Beta M, Venkatesan N, Vasudevan M, Vetrivel U, Khetan V, Krishnakumar S. Identification and Insilico Analysis of Retinoblastoma Serum microRNA Profile and Gene Targets Towards Prediction of Novel Serum Biomarkers. Bioinform Biol Insights 2013;7:21-34. [PMID: 23400111 DOI: 10.4137/BBI.S10501] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]